Role of PAI-1 in the progression and treatment resistance of non-small cell lung cancer.

Biomed J · 2026 · PMC12859764 · PMID 40915498

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Similarly, another study that included 118 patients with NSCLC, comprising a higher proportion of squamous and large cell carcinoma, showed a trend toward poorer prognosis in the high PAI-1 group.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.